|
Market Closed -
Other stock markets
|
Pre-market 12:16:52 pm | |||
| 58.52 EUR | -1.38% |
|
58.00 | -0.89% |
| 11/05 | CAC 40: Luxury and Geopolitics Weigh on Sentiment | |
| 11/05 | Eurofins among top CAC 40 decliners as BofA downgrades |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 671.77Cr | 671.21Cr | 651.46Cr | 695.1Cr | 729.61Cr | |||||
Total Revenues | 671.77Cr | 671.21Cr | 651.46Cr | 695.1Cr | 729.61Cr | |||||
Cost of Goods Sold, Total | 480.39Cr | 518.58Cr | 513.99Cr | 539.08Cr | 565.52Cr | |||||
Gross Profit | 191.38Cr | 152.63Cr | 137.47Cr | 156.02Cr | 164.09Cr | |||||
Selling General & Admin Expenses, Total | 1.28Cr | 1.42Cr | 1.31Cr | 1.05Cr | 21L | |||||
Stock-Based Compensation (IS) | 12Cr | 13Cr | 12Cr | 12Cr | 11Cr | |||||
Depreciation & Amortization - (IS) | 43Cr | 48Cr | 52Cr | 54Cr | 56Cr | |||||
Other Operating Expenses, Total | 56Cr | 62Cr | 66Cr | 66Cr | 68Cr | |||||
Operating Income | 135.23Cr | 91Cr | 72Cr | 90Cr | 96Cr | |||||
Interest Expense, Total | -9.43Cr | -9.16Cr | -12Cr | -15Cr | -15Cr | |||||
Net Interest Expenses | -9.43Cr | -9.16Cr | -12Cr | -15Cr | -15Cr | |||||
Income (Loss) On Equity Invest. | 20L | 9L | 4L | 10L | 3L | |||||
Currency Exchange Gains (Loss) | -1.79Cr | -3.29Cr | 1.12Cr | 49L | 2.46Cr | |||||
Other Non Operating Income (Expenses) | 18L | -1.16Cr | 72L | 1.71Cr | 7L | |||||
EBT, Excl. Unusual Items | 124.39Cr | 77Cr | 61Cr | 77Cr | 84Cr | |||||
Restructuring Charges | -3.22Cr | - | - | - | -6.81Cr | |||||
Merger & Related Restructuring Charges | -1.36Cr | -87L | -1.51Cr | -2.41Cr | -2.55Cr | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | 14Cr | -18L | -2.36Cr | -89L | |||||
Other Unusual Items | -14Cr | -13Cr | -17Cr | -17Cr | -7.88Cr | |||||
EBT, Incl. Unusual Items | 105.66Cr | 78Cr | 42Cr | 55Cr | 65Cr | |||||
Income Tax Expense | 27Cr | 17Cr | 12Cr | 15Cr | 18Cr | |||||
Earnings From Continuing Operations | 78Cr | 61Cr | 31Cr | 41Cr | 47Cr | |||||
Net Income to Company | 78Cr | 61Cr | 31Cr | 41Cr | 47Cr | |||||
Minority Interest | -4L | 44L | 25L | 9L | 18L | |||||
Net Income - (IS) | 78Cr | 61Cr | 31Cr | 41Cr | 47Cr | |||||
Preferred Dividend and Other Adjustments | 3.41Cr | 2.93Cr | 5.37Cr | 5.01Cr | 5.87Cr | |||||
Net Income to Common Incl Extra Items | 75Cr | 58Cr | 26Cr | 36Cr | 42Cr | |||||
Net Income to Common Excl. Extra Items | 75Cr | 58Cr | 26Cr | 36Cr | 42Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.91 | 3.02 | 1.33 | 1.87 | 2.31 | |||||
Basic EPS - Continuing Operations | 3.91 | 3.02 | 1.33 | 1.87 | 2.31 | |||||
Basic Weighted Average Shares Outstanding | 19Cr | 19Cr | 19Cr | 19Cr | 18Cr | |||||
Net EPS - Diluted | 3.73 | 2.92 | 1.3 | 1.83 | 2.23 | |||||
Diluted EPS - Continuing Operations | 3.73 | 2.92 | 1.3 | 1.83 | 2.23 | |||||
Diluted Weighted Average Shares Outstanding | 20Cr | 20Cr | 20Cr | 19Cr | 19Cr | |||||
Normalized Basic EPS | 4.06 | 2.53 | 2 | 2.54 | 2.91 | |||||
Normalized Diluted EPS | 3.87 | 2.45 | 1.95 | 2.49 | 2.81 | |||||
Dividend Per Share | 1 | 1 | 0.5 | 0.6 | 0.72 | |||||
Payout Ratio | 21.22 | 37.36 | 75.4 | 36.69 | 33.15 | |||||
American Depositary Receipts Ratio (ADR) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |||||
Supplemental Items | ||||||||||
EBITDA | 174.79Cr | 135.25Cr | 118.71Cr | 136.69Cr | 145.52Cr | |||||
EBITA | 144.99Cr | 101.32Cr | 82Cr | 99Cr | 105.71Cr | |||||
EBIT | 135.23Cr | 91Cr | 72Cr | 90Cr | 96Cr | |||||
EBITDAR | 176Cr | 136.59Cr | 119.81Cr | 137.49Cr | - | |||||
Effective Tax Rate - (Ratio) | 25.89 | 22.33 | 27.29 | 26.88 | 27.69 | |||||
Total Current Taxes | 30Cr | 20Cr | 16Cr | 19Cr | 16Cr | |||||
Total Deferred Taxes | -2.63Cr | -2.7Cr | -4.14Cr | -3.59Cr | 1.66Cr | |||||
Normalized Net Income | 78Cr | 49Cr | 39Cr | 48Cr | 52Cr | |||||
Interest on Long-Term Debt | 7.27Cr | 7.63Cr | 11Cr | 12Cr | 12Cr | |||||
Non-Cash Pension Expense | 5L | 4L | 22L | 21L | 21L | |||||
Supplemental Operating Expense Items | ||||||||||
Net Rental Expense, Total | 1.21Cr | 1.34Cr | 1.1Cr | 80L | - | |||||
Imputed Operating Lease Interest Expense | 30.9L | 32.3L | 29.95L | 24.88L | - | |||||
Imputed Operating Lease Depreciation | 90.1L | 1.02Cr | 80.05L | 55.12L | - | |||||
Stock-Based Comp., Other (Total) | 12Cr | 13Cr | 12Cr | 12Cr | 11Cr | |||||
Total Stock-Based Compensation | 12Cr | 13Cr | 12Cr | 12Cr | 11Cr |
- Stock Market
- Equities
- ERF Stock
- Financials Eurofins Scientific SE
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















